儿童中耳胆脂瘤诊治进展

doi:10.6040/j.issn.1673-3770.0.2021.503

摘要/Abstract

摘要： 儿童中耳胆脂瘤在患病率、发病机制与临床表现等方面都具有人群的特殊性。其起病隐匿,早期诊治成为临床难点。随着对儿童中耳胆脂瘤认识的提高和普及,临床中对此疾病的关注度明显提高。临床分期的应用及手术治疗的精准性趋于完善,伴有腭裂、特纳综合征、唐氏综合症等特殊人群的中耳胆脂瘤患儿的远期预后管理也得到了重视。

关键词: 儿童, 中耳胆脂瘤, 病理生理, 临床分期, 手术策略

Abstract: Middle ear cholesteatoma in children has population specificity in terms of prevalence, pathogenesis, and clinical manifestations. Due to its gradual onset, early diagnosis and treatment have become difficult clinically. With the improvement and popularization of middle ear cholesteatoma in children, this disease is becoming of increasing interest. The application of clinical staging and the accuracy of surgical treatment have greatly improved. The long-term prognosis management of middle ear cholesteatoma in children with cleft palate, Turner syndrome, Down syndrome, and other special populations has also been given importance.

Key words: Children, Middle ear cholesteatoma, Pathophysiology, Clinical stage, Surgical strategy

中图分类号:

R764.29

杨扬, 王晓旭, 张杰. 儿童中耳胆脂瘤诊治进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 1-6.

YANG Yang, WANG Xiaoxu, ZHANG Jie. Progress on diagnosis and treatment of middle ear cholesteatoma in children[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 1-6.

参考文献

[1] Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma[J]. J Int Adv Otol, 2017, 13(1): 1-8. doi:10.5152/iao.2017.3363.
[2] Jackson R, Addison AB, Prinsley PR. Cholesteatoma in children and adults: are there really any differences?[J]. J Laryngol Otol, 2018, 132(7): 575-578. doi:10.1017/S0022215118000890.
[3] Nevoux J, Lenoir M, Roger G, et al. Childhood cholesteatoma[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2010, 127(4): 143-150. doi:10.1016/j.anorl.2010.07.001.
[4] Thomas JP, Volkenstein S, Minovi A, et al. Current aspects of paediatric cholesteatomas[J]. HNO, 2013, 61(5): 380-387. doi:10.1007/s00106-012-2641-8.
[5] Minovi A, Dazert S. Diseases of the middle ear in childhood[J]. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2014, 13: Doc11. doi:10.3205/cto000114.
[6] Johannes ML. Ueber den feinern Bau und die Formen der krankhaften Geschwuülste [M]. Berlin: G. Reimer, 1838.
[7] Shin SH, Huang M, Kim SH, et al. Differential protein expression in congenital and acquired cholesteatomas[J]. PLoS One, 2015, 10(9): e0137011. doi:10.1371/journal.pone.0137011.
[8] Lindeman P, Holmquist J. Mastoid volume and eustachian tube function in ears with cholesteatoma[J]. Am J Otol, 1987, 8(1): 5-7.
[9] Kuo CL. Etiopathogenesis of acquired cholesteatoma: prominent theories and recent advances in biomolecular research[J]. Laryngoscope, 2015, 125(1): 234-240. doi:10.1002/lary.24890.
[10] Yamamoto-Fukuda T, Akiyama N, Tatsumi N, et al. Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo[J]. Int J Pediatr Otorhinolaryngol, 2021, 140: 110545. doi:10.1016/j.ijporl.2020.110545.
[11] Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research[J]. Biomed Res Int, 2015, 2015: 854024. doi:10.1155/2015/854024.
[12] Uzun T, Çaklı H, Co??塂an DT, et al. In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma[J]. Int J Pediatr Otorhinolaryngol, 2021, 145: 110743. doi:10.1016/j.ijporl.2021.110743.
[13] Maniu A, Harabagiu O, Perde Schrepler M, et al. Molecular biology of cholesteatoma[J]. Romanian J Morphol Embryol, 2014, 55(1): 7-13.
[14] Fontes Lima A, Carvalho Moreira F, Sousa Menezes A, et al. Is pediatric cholesteatoma more aggressive in children than in adults? A comparative study using the EAONO/JOS classification[J]. Int J Pediatr Otorhinolaryngol, 2020, 138: 110170. doi:10.1016/j.ijporl.2020.110170.
[15] Preciado DA. Biology of cholesteatoma: special considerations in pediatric patients[J]. Int J Pediatr Otorhinolaryngol, 2012, 76(3): 319-321. doi:10.1016/j.ijporl.2011.12.014.
[16] Derlacki EL, Clemis JD. Congenital cholesteatoma of the middle ear and mastoid[J]. Ann Otol Rhinol Laryngol, 1965, 74(3): 706-727. doi:10.1177/000348946507400313.
[17] Levenson MJ, Michaels L, Parisier SC. Congenital cholesteatomas of the middle ear in children: origin and management[J]. Otolaryngol Clin North Am, 1989, 22(5): 941-954.
[18] Potsic WP, Samadi DS, Marsh RR, et al. A staging system for congenital cholesteatoma[J]. Arch Otolaryngol Head Neck Surg, 2002, 128(9): 1009-1012. doi:10.1001/archotol.128.9.1009.
[19] Nelson M, Roger G, Koltai PJ, et al. Congenital cholesteatoma: classification, management, and outcome[J]. Arch Otolaryngol Head Neck Surg, 2002, 128(7): 810-814. doi:10.1001/archotol.128.7.810.
[20] Rutkowska J, Özgirgin N, Olszewska E. Cholesteatoma definition and classification: a literature review[J]. J Int Adv Otol, 2017, 13(2): 266-271. doi:10.5152/iao.2017.3411.
[21] Lau T, Tos M. Tensa retraction cholesteatoma: treatment and long-term results[J]. J Laryngol Otol, 1989, 103(2): 149-157. doi:10.1017/s0022215100108321.
[22] Merkus P, Ten Tije FA, Stam M, et al. Implementation of the “EAONO/JOS definitions and classification of middle ear cholesteatoma”-from STAM to STAMCO[J]. J Int Adv Otol, 2017, 13(2): 272-275. doi:10.5152/iao.2017.4049.
[23] Linder TE, Shah S, Martha AS, et al. Introducing the “ChOLE” classification and its comparison to the EAONO/JOS consensus classification for cholesteatoma staging[J]. Otol Neurotol, 2019, 40(1): 63-72. doi:10.1097/MAO.0000000000002039.
[24] Cacco T, Africano S, Gaglio G, et al. Correlation between peri-operative complication in middle ear cholesteatoma surgery using STAMCO, ChOLE, and SAMEO-ATO classifications[J]. Eur Arch Otorhinolaryngol, 2021: 22. doi:10.1007/s00405-021-06679-8.
[25] van der Toom H, van der Schroeff MP, Janssen J, et al. A retrospective analysis and comparison of the STAM and STAMCO classification and EAONO/JOS cholesteatoma staging system in predicting surgical treatment outcomes of middle ear cholesteatoma[J]. Otol Neurotol, 2020, 41(4): e468-e474. doi:10.1097/MAO.0000000000002549.
[26] Ten Tije FA, Merkus P, Buwalda J, et al. Practical applicability of the STAMCO and ChOLE classification in cholesteatoma care [J]. Eur Arch Otorhinolaryngol,2021,278(10):3777-3787. doi: 10.1007/s00405-020-06478-7.
[27] Bächinger D, Rrahmani A, Weiss NM, et al. Evaluating hearing outcome, recidivism and complications in cholesteatoma surgery using the ChOLE classification system[J]. Eur Arch Otorhinolaryngol, 2021, 278(5): 1365-1371. doi:10.1007/s00405-020-06208-z.
[28] Dixon PR, James AL. Evaluation of residual disease following transcanal totally endoscopic vs postauricular surgery among children with middle ear and attic cholesteatoma[J]. JAMA Otolaryngol Head Neck Surg, 2020, 146(5): 408-413. doi:10.1001/jamaoto.2020.0001.
[29] Nogueira JF, Cohen MS. Combined endoscopic and microscopic approaches to cholesteatoma[J]. Oper Tech Otolaryngol - Head Neck Surg, 2017, 28(1): 36-38. doi:10.1016/j.otot.2017.01.006.
[30] Denoyelle F, Simon F, Chang KW, et al. International pediatric otolaryngology group(IPOG)consensus recommendations: congenital cholesteatoma[J]. Otol Neurotol, 2020, 41(3): 345-351. doi:10.1097/mao.0000000000002521.
[31] McRackan TR, Abdellatif WM, Wanna GB, et al. Evaluation of second look procedures for pediatric cholesteatomas[J]. Otolaryngol-Head Neck Surg, 2011, 145(1): 154-160. doi:10.1177/0194599810396624.
[32] Bazzi K, Wong E, Jufas N, et al. Diffusion-weighted magnetic resonance imaging in the detection of residual and recurrent cholesteatoma in children: a systematic review and meta-analysis[J]. Int J Pediatr Otorhinolaryngol, 2019, 118: 90-96. doi:10.1016/j.ijporl.2018.12.031.
[33] Sharifian H, Taheri E, Borghei P, et al. Diagnostic accuracy of non-echo-planar diffusion-weighted MRI versus other MRI sequences in cholesteatoma[J]. J Med Imaging Radiat Oncol, 2012, 56(4): 398-408. doi:10.1111/j.1754-9485.2012.02377.x.
[34] Harris L, Cushing SL, Hubbard B, et al. Impact of cleft palate type on the incidence of acquired cholesteatoma[J]. Int J Pediatr Otorhinolaryngol, 2013, 77(5): 695-698. doi:10.1016/j.ijporl.2013.01.020.
[35] Lourençone LFM, Batistão GT, de Cassia Rillo Dutka J, et al. Management of acquired cholesteatoma in patients with craniofacial anomalies: an institutional experience[J]. Am J Otolaryngol, 2020, 41(6): 102591. doi:10.1016/j.amjoto.2020.102591.
[36] Beckman A, Conway GS, Cadge B. Audiological features of Turner's syndrome in adults[J]. Int J Audiol, 2004, 43(9): 533-544. doi:10.1080/14992020400050068.
[37] Verver EJ, Freriks K, Thomeer HG, et al. Ear and hearing problems in relation to karyotype in children with Turner syndrome[J]. Hear Res, 2011, 275(1/2): 81-88. doi:10.1016/j.heares.2010.12.007.
[38] Lim DB, Gault EJ, Kubba H, et al. Cholesteatoma has a high prevalence in Turner syndrome, highlighting the need for earlier diagnosis and the potential benefits of otoscopy training for paediatricians[J]. Acta Paediatr, 2014, 103(7): e282-e287. doi:10.1111/apa.12622.
[39] 郝津生, 苏畅, 闫洁, 等. 儿童Turner综合征听力学特点[J]. 中华耳科学杂志, 2015, 13(3): 440-444. doi:10.3969/j.issn.1672-2922.2015.03.013. HAO Jinsheng, SU Chang, YAN Jie, et al. Audiologic features of ethnic Chinese patients with Turner syndrome[J]. Chin J Otol, 2015, 13(3): 440-444. doi:10.3969/j.issn.1672-2922.2015.03.013.
[40] Zanetti D, di Lella F, Negri M, et al. Surgical management of middle ear cholesteatoma in children with Turner syndrome: a multicenter experience[J]. Acta Biomed, 2018, 89(3): 382-388. doi:10.23750/abm.v89i3.5409.
[41] Spinner A, Munjuluru A, Wootten CT. Prevalence of cholesteatoma in children with Down syndrome receiving treatment at pediatric health care facilities[J]. JAMA Otolaryngol Head Neck Surg, 2020, 146(9): 864-865. doi:10.1001/jamaoto.2020.1854.
[42] Ghadersohi S, Bhushan B, Billings KR. Challenges and outcomes of cholesteatoma management in children with Down syndrome[J]. Int J Pediatr Otorhinolaryngol, 2018, 106: 80-84. doi:10.1016/j.ijporl.2018.01.016.

相关文章 15

[1]	朱希倩,王佳,孙祖贤,冯建秀,张梦佳,赵颖,王宏,姜敏敏. 上海市杨浦区2022—2024年6~9岁学龄儿童屈光状态分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 102-109.
[2]	宋艳玲,司元元,崔彦. 微量玻璃体切除治疗激光笔致儿童全层黄斑裂孔1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 144-147.
[3]	刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25.
[4]	黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[5]	王华,张丰珍,龙婷,赵靖,李宏彬,王生才,王桂香. 后颅窝肿瘤术后儿童气管切开原因及预后转归分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 168-173.
[6]	乐冰艳,邹剑,雷蕾,文巧,钱应雪. 儿童扁桃体微生物群与免疫调节及疾病关联[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 193-200.
[7]	黄爱萍,王娟,王丽,耿江桥,王亚芳,温鑫. 儿童原发扁桃体Burkitt淋巴瘤累及上颌骨和肺1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 148-152.
[8]	刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[9]	付圣尧,陈敏,庞文会,李娜. 内镜辅助个体化手术入路治疗儿童鼻中线囊肿及瘘管[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 65-71.
[10]	陈丹萍,何子键,虞幼军,周晓娓. 儿童突发性聋10年住院病例的疗效及预后相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 16-22.
[11]	杨娜,柳荫,郭宝,纪尧峰,成晨,张琛,董丽娜. 高频超声在儿童鼻骨骨折闭合复位术的应用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 41-45.
[12]	王登茂,温鑫,耿江桥,张光远,刘晓峰. 儿童咽鼓管毛息肉合并鼻咽部错构瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 105-109.
[13]	姚婷婷,张德伦,李兰. 婴儿下咽部胃黏膜异位症引发咽喉反流症状1例并文献回顾[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 126-130.
[14]	罗露,周恩,肖旭平,林志强,方志杰,吕晓虹. 等离子点状激发技术在儿童OSA扁桃体腺样体切除术联合围手术期快速康复中的应用[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 26-30.
[15]	张杰,陈敏,申征征,吴宇华,刘原虎,孙浩,谭新华,倪树仁,杨书勋,史雪峥,倪鑫. 过敏性鼻炎与儿童新冠病毒肺炎感染及症状的关联性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(4): 36-42.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed